A detailed history of Wells Fargo & Company transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 25 shares of CLPT stock, worth $318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 6,970 99.64%
Holding current value
$318
Previous $47,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.25 - $6.73 $36,461 - $46,739
-6,945 Reduced 99.64%
25 $0
Q1 2024

May 10, 2024

BUY
$6.03 - $7.86 $5,577 - $7,270
925 Added 15.3%
6,970 $47,000
Q4 2023

Feb 09, 2024

BUY
$4.46 - $7.07 $6,043 - $9,579
1,355 Added 28.89%
6,045 $41,000
Q3 2023

Nov 13, 2023

SELL
$5.01 - $7.09 $243,796 - $345,013
-48,662 Reduced 91.21%
4,690 $23,000
Q2 2023

Aug 15, 2023

BUY
$6.54 - $10.58 $347,757 - $562,580
53,174 Added 29873.03%
53,352 $386,000
Q1 2023

May 12, 2023

BUY
$7.33 - $10.63 $14 - $21
2 Added 1.14%
178 $1,000
Q4 2022

Feb 13, 2023

BUY
$7.7 - $11.21 $38 - $56
5 Added 2.92%
176 $1,000
Q3 2022

Nov 14, 2022

BUY
$9.82 - $16.49 $314 - $527
32 Added 23.02%
171 $2,000
Q2 2022

Aug 12, 2022

SELL
$7.09 - $13.65 $44,631 - $85,926
-6,295 Reduced 97.84%
139 $1,000
Q1 2022

May 16, 2022

SELL
$7.8 - $11.6 $51,792 - $77,024
-6,640 Reduced 50.79%
6,434 $67,000
Q4 2021

Feb 14, 2022

SELL
$11.08 - $18.86 $403,134 - $686,202
-36,384 Reduced 73.57%
13,074 $146,000
Q3 2021

Nov 15, 2021

BUY
$16.58 - $22.25 $769,842 - $1.03 Million
46,432 Added 1534.43%
49,458 $877,000
Q2 2021

Aug 16, 2021

BUY
$17.23 - $22.77 $43,764 - $57,835
2,540 Added 522.63%
3,026 $58,000
Q1 2021

May 13, 2021

BUY
$15.19 - $29.0 $6,243 - $11,919
411 Added 548.0%
486 $10,000
Q4 2020

Feb 09, 2021

BUY
$5.11 - $15.89 $45 - $143
9 Added 13.64%
75 $1,000
Q1 2020

May 14, 2020

BUY
$3.33 - $6.14 $219 - $405
66 New
66 $0

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $312M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.